Peer review reports
From: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome
Original Submission | ||
---|---|---|
5 Apr 2019 | Submitted | Original manuscript |
29 Dec 2019 | Reviewed | Reviewer Report - Daisy Kosa |
13 Jan 2020 | Reviewed | Reviewer Report - Jonathan Adachi |
21 Feb 2020 | Author responded | Author comments - Kimberly Legault |
Resubmission - Version 2 | ||
21 Feb 2020 | Submitted | Manuscript version 2 |
Publishing | ||
3 Apr 2020 | Editorially accepted | |
25 Apr 2020 | Article published | 10.1186/s40814-020-00594-1 |